The COVID-19 vaccine is a constant point of discussion in our industry and beyond. Unfortunately, at this stage there are significantly more questions than answers.
There will certainly be new challenges, but nothing that cannot be addressed by carefully examining and responding to the facts. We encourage you to use these uncertain times to actively solicit new submissions and reinforce our shared clients.
This excerpt was from the February 2021 "Vaccine" ProVisions, our monthly ProAssurance healthcare professional liability newsletter for agents. The issue was emailed this week and is posted to the secure services portal (SSP).
Visit the ProVisions page read this or past issues.
Agents not currently receiving ProVisions by email, please let us know.